-transparent.png){kind=logo}
Normal human monocyte-macrophages were cholesterol-loaded, and the rates of uptake and degradation of several lipoproteins were measured and compared to rates in control cells. Receptor activities for 125I-rabbit beta-very low density lipoproteins (beta-VLDL), 125I-human low density lipoprotein, and 125I-human chylomicrons were down-regulated in cholesterol-loaded cells; however, the rate of uptake and degradation of 125I-human chylomicron remnants was unchanged from control cells. Cholesterol-loaded alveolar macrophages from a Watanabe heritable hyperlipidemic rabbit, which lack low density lipoprotein receptors, showed receptor down-regulation for 125I-beta-VLDL but not for 125I-human chylomicron remnants. In addition to chylomicron remnants, apo-E-phospholipid complexes competed for 125I-chylomicron remnant uptake, but apo-A-I-phospholipid complexes did not. Chylomicrons competed for lipoprotein uptake in control cells but were not recognized under conditions of cholesterol loading. Chylomicron remnants and beta-VLDL were equally effective in competing for 125I-beta-VLDL and 125I-chylomicron remnant uptake in cholesterol-loaded macrophages. When normal human monocyte-macrophages were incubated in serum supplemented with chylomicron remnants, the cholesteryl ester content increased 4-fold over cells incubated in serum with low density lipoprotein added. We conclude: 1) specific lipoprotein receptor activity persists in cholesterol-loaded cells; 2) this receptor activity recognizes lipo-proteins (at least in part) by their apo-E content; and 3) cholesteryl ester accumulation can occur in monocyte-macrophages incubated with chylomicron remnants.
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
May 1988,
The Journal of clinical investigation,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
August 1989,
Biochimica et biophysica acta,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
October 2006,
Atherosclerosis,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
August 1990,
The Journal of biological chemistry,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
January 1985,
Biochemical and biophysical research communications,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
October 1982,
Lipids,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
July 1985,
Biochimica et biophysica acta,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
September 1981,
Biochimica et biophysica acta,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
September 1982,
Journal of lipid research,
B J Van Lenten, and
A M Fogelman, and
R L Jackson, and
S Shapiro, and
M E Haberland, and
P A Edwards
May 2001,
The Journal of pharmacy and pharmacology,
